Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 408

1.

Reduced stomatal density in bread wheat leads to increased water-use efficiency.

Dunn J, Hunt L, Afsharinafar M, Al Meselmani M, Mitchell A, Howells R, Wallington E, Fleming AJ, Gray JE.

J Exp Bot. 2019 Jun 6. pii: erz248. doi: 10.1093/jxb/erz248. [Epub ahead of print]

PMID:
31172183
2.

Bacterial infection systemically suppresses stomatal density.

Dutton C, Hõrak H, Hepworth C, Mitchell A, Ton J, Hunt L, Gray JE.

Plant Cell Environ. 2019 May 1. doi: 10.1111/pce.13570. [Epub ahead of print]

PMID:
31042812
3.

Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer.

Sequist LV, Gray JE, Harb WA, Lopez-Chavez A, Doebele RC, Modiano MR, Jackman DM, Baggstrom MQ, Atmaca A, Felip E, Provencio M, Cobo M, Adiwijaya B, Kuesters G, Kamoun WS, Andreas K, Pipas JM, Santillana S, Cho BC, Park K, Shepherd FA.

Oncologist. 2019 Apr 11. pii: theoncologist.2018-0695. doi: 10.1634/theoncologist.2018-0695. [Epub ahead of print]

PMID:
30975923
4.

Rice plants overexpressing OsEPF1 show reduced stomatal density and increased root cortical aerenchyma formation.

Mohammed U, Caine RS, Atkinson JA, Harrison EL, Wells D, Chater CC, Gray JE, Swarup R, Murchie EH.

Sci Rep. 2019 Apr 3;9(1):5584. doi: 10.1038/s41598-019-41922-7.

5.

Loneliness as a mediator of the relationship of social cognitive variables with depressive symptoms and quality of life in lung cancer patients beginning treatment.

Hyland KA, Small BJ, Gray JE, Chiappori A, Creelan BC, Tanvetyanon T, Nelson AM, Cessna-Palas J, Jim HSL, Jacobsen PB.

Psychooncology. 2019 Jun;28(6):1234-1242. doi: 10.1002/pon.5072. Epub 2019 May 3.

PMID:
30932275
6.

Impact of Stomatal Density and Morphology on Water-Use Efficiency in a Changing World.

Bertolino LT, Caine RS, Gray JE.

Front Plant Sci. 2019 Mar 6;10:225. doi: 10.3389/fpls.2019.00225. eCollection 2019. Review.

7.

Targeting Trop-2 in solid tumors: future prospects.

Zaman S, Jadid H, Denson AC, Gray JE.

Onco Targets Ther. 2019 Mar 1;12:1781-1790. doi: 10.2147/OTT.S162447. eCollection 2019. Review.

8.

Phase 1 trial of dasatinib combined with afatinib for epidermal growth factor receptor- (EGFR-) mutated lung cancer with acquired tyrosine kinase inhibitor (TKI) resistance.

Creelan BC, Gray JE, Tanvetyanon T, Chiappori AA, Yoshida T, Schell MJ, Antonia SJ, Haura EB.

Br J Cancer. 2019 Apr;120(8):791-796. doi: 10.1038/s41416-019-0428-3. Epub 2019 Mar 18.

PMID:
30880334
9.

Novel clinical and radiomic predictors of rapid disease progression phenotypes among lung cancer patients treated with immunotherapy: An early report.

Tunali I, Gray JE, Qi J, Abdalah M, Jeong DK, Guvenis A, Gillies RJ, Schabath MB.

Lung Cancer. 2019 Mar;129:75-79. doi: 10.1016/j.lungcan.2019.01.010. Epub 2019 Jan 23.

PMID:
30797495
10.

Postprogression Outcomes for Osimertinib versus Standard-of-Care EGFR-TKI in Patients with Previously Untreated EGFR-mutated Advanced Non-Small Cell Lung Cancer.

Planchard D, Boyer MJ, Lee JS, Dechaphunkul A, Cheema PK, Takahashi T, Gray JE, Tiseo M, Ramalingam SS, Todd A, McKeown A, Rukazenkov Y, Ohe Y.

Clin Cancer Res. 2019 Apr 1;25(7):2058-2063. doi: 10.1158/1078-0432.CCR-18-3325. Epub 2019 Jan 18.

PMID:
30659024
11.

Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer.

Chiappori AA, Williams CC, Gray JE, Tanvetyanon T, Haura EB, Creelan BC, Thapa R, Chen DT, Simon GR, Bepler G, Gabrilovich DI, Antonia SJ.

Cancer Immunol Immunother. 2019 Mar;68(3):517-527. doi: 10.1007/s00262-018-2287-9. Epub 2018 Dec 27.

12.

Clinical associations of mucin 1 in human lung cancer and precancerous lesions.

Saltos A, Khalil F, Smith M, Li J, Schell M, Antonia SJ, Gray JE.

Oncotarget. 2018 Nov 2;9(86):35666-35675. doi: 10.18632/oncotarget.26278. eCollection 2018 Nov 2.

13.

Variability in antimicrobial use in pediatric ventilator-associated events.

Karandikar MV, Coffin SE, Priebe GP, Sandora TJ, Logan LK, Larsen GY, Toltzis P, Gray JE, Klompas M, Sammons JS, Harper MB, Horan K, Lakoma M, Cocoros NM, Lee GM.

Infect Control Hosp Epidemiol. 2019 Jan;40(1):32-39. doi: 10.1017/ice.2018.264. Epub 2018 Nov 9.

PMID:
30409233
14.

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.

Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Kurata T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim YC, Karapetis CS, Hiret S, Ostoros G, Kubota K, Gray JE, Paz-Ares L, de Castro Carpeño J, Faivre-Finn C, Reck M, Vansteenkiste J, Spigel DR, Wadsworth C, Melillo G, Taboada M, Dennis PA, Özgüroğlu M; PACIFIC Investigators.

N Engl J Med. 2018 Dec 13;379(24):2342-2350. doi: 10.1056/NEJMoa1809697. Epub 2018 Sep 25.

PMID:
30280658
15.

Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in EGFR-Mutant NSCLC.

Le X, Puri S, Negrao MV, Nilsson MB, Robichaux J, Boyle T, Hicks JK, Lovinger KL, Roarty E, Rinsurongkawong W, Tang M, Sun H, Elamin Y, Lacerda LC, Lewis J, Roth JA, Swisher SG, Lee JJ, William WN Jr, Glisson BS, Zhang J, Papadimitrakopoulou VA, Gray JE, Heymach JV.

Clin Cancer Res. 2018 Dec 15;24(24):6195-6203. doi: 10.1158/1078-0432.CCR-18-1542. Epub 2018 Sep 18.

PMID:
30228210
16.

A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma.

Gray JE, Chiappori A, Williams CC, Tanvetyanon T, Haura EB, Creelan BC, Kim J, Boyle TA, Pinder-Schenck M, Khalil F, Altiok S, Devane R, Noyes D, Mediavilla-Varela M, Smilee R, Hopewell EL, Kelley L, Antonia SJ.

Cancer Immunol Immunother. 2018 Dec;67(12):1853-1862. doi: 10.1007/s00262-018-2236-7. Epub 2018 Sep 12.

17.

Models and Mechanisms of Stomatal Mechanics.

Woolfenden HC, Baillie AL, Gray JE, Hobbs JK, Morris RJ, Fleming AJ.

Trends Plant Sci. 2018 Sep;23(9):822-832. doi: 10.1016/j.tplants.2018.06.003. Epub 2018 Jun 28. Review.

PMID:
30149855
18.

Distinct branches of the N-end rule pathway modulate the plant immune response.

Vicente J, Mendiondo GM, Pauwels J, Pastor V, Izquierdo Y, Naumann C, Movahedi M, Rooney D, Gibbs DJ, Smart K, Bachmair A, Gray JE, Dissmeyer N, Castresana C, Ray RV, Gevaert K, Holdsworth MJ.

New Phytol. 2019 Jan;221(2):988-1000. doi: 10.1111/nph.15387. Epub 2018 Aug 17.

19.

A reality check for climate change experiments: Do they reflect the real world?

Knapp AK, Carroll CJW, Griffin-Nolan RJ, Slette IJ, Chaves FA, Baur LE, Felton AJ, Gray JE, Hoffman AM, Lemoine NP, Mao W, Post AK, Smith MD.

Ecology. 2018 Oct;99(10):2145-2151. doi: 10.1002/ecy.2474. Epub 2018 Sep 4.

PMID:
30054917
20.

Rice with reduced stomatal density conserves water and has improved drought tolerance under future climate conditions.

Caine RS, Yin X, Sloan J, Harrison EL, Mohammed U, Fulton T, Biswal AK, Dionora J, Chater CC, Coe RA, Bandyopadhyay A, Murchie EH, Swarup R, Quick WP, Gray JE.

New Phytol. 2019 Jan;221(1):371-384. doi: 10.1111/nph.15344. Epub 2018 Jul 24.

21.

Midwifery pre-registration education and mid-career workforce participation and experiences.

Sheehy A, Smith RM, Gray JE, Homer CSE.

Women Birth. 2019 Apr;32(2):e182-e188. doi: 10.1016/j.wombi.2018.06.014. Epub 2018 Jul 2.

PMID:
30042066
22.

Immune Checkpoint Inhibitors in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer.

Puri S, Shafique M, Gray JE.

Curr Treat Options Oncol. 2018 Jun 21;19(8):39. doi: 10.1007/s11864-018-0556-7. Review.

PMID:
29931587
23.

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.

Gandhi L, Rodríguez-Abreu D, Gadgeel S, Esteban E, Felip E, De Angelis F, Domine M, Clingan P, Hochmair MJ, Powell SF, Cheng SY, Bischoff HG, Peled N, Grossi F, Jennens RR, Reck M, Hui R, Garon EB, Boyer M, Rubio-Viqueira B, Novello S, Kurata T, Gray JE, Vida J, Wei Z, Yang J, Raftopoulos H, Pietanza MC, Garassino MC; KEYNOTE-189 Investigators.

N Engl J Med. 2018 May 31;378(22):2078-2092. doi: 10.1056/NEJMoa1801005. Epub 2018 Apr 16.

24.

Immunotherapy combination strategies (non-chemotherapy) in non-small cell lung cancer.

Niyongere S, Saltos A, Gray JE.

J Thorac Dis. 2018 Feb;10(Suppl 3):S433-S450. doi: 10.21037/jtd.2017.12.120. Review.

25.

Prediction of chemotherapy-induced nausea and vomiting from patient-reported and genetic risk factors.

Puri S, Hyland KA, Weiss KC, Bell GC, Gray JE, Kim R, Lin HY, Hoogland AI, Gonzalez BD, Nelson AM, Kinney AY, Fischer SM, Li D, Jacobsen PB, McLeod HL, Jim HSL.

Support Care Cancer. 2018 Aug;26(8):2911-2918. doi: 10.1007/s00520-018-4120-6. Epub 2018 Mar 15.

PMID:
29546524
26.

Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study.

Garassino MC, Cho BC, Kim JH, Mazières J, Vansteenkiste J, Lena H, Corral Jaime J, Gray JE, Powderly J, Chouaid C, Bidoli P, Wheatley-Price P, Park K, Soo RA, Huang Y, Wadsworth C, Dennis PA, Rizvi NA; ATLANTIC Investigators.

Lancet Oncol. 2018 Apr;19(4):521-536. doi: 10.1016/S1470-2045(18)30144-X. Epub 2018 Mar 12.

PMID:
29545095
27.

Molecular control of stomatal development.

Zoulias N, Harrison EL, Casson SA, Gray JE.

Biochem J. 2018 Jan 31;475(2):441-454. doi: 10.1042/BCJ20170413. Review.

28.

The BIG protein distinguishes the process of CO2 -induced stomatal closure from the inhibition of stomatal opening by CO2.

He J, Zhang RX, Peng K, Tagliavia C, Li S, Xue S, Liu A, Hu H, Zhang J, Hubbard KE, Held K, McAinsh MR, Gray JE, Kudla J, Schroeder JI, Liang YK, Hetherington AM.

New Phytol. 2018 Apr;218(1):232-241. doi: 10.1111/nph.14957. Epub 2018 Jan 2.

29.

Patient, caregiver and physician perspectives on participating in a thoracic rapid tissue donation program.

Quinn GP, Pentz RD, Muñoz-Antonia T, Boyle TA, Schabath MB, Pratt CL, Shaffer A, Duarte LF, Bowman-Curci M, Antonia SJ, Chiappori AA, Creelan BC, Gray JE, Williams CC, Haura EB.

Patient Educ Couns. 2018 Apr;101(4):703-710. doi: 10.1016/j.pec.2017.11.014. Epub 2017 Nov 28.

30.

A Bayesian pick-the-winner design in a randomized phase II clinical trial.

Chen DT, Huang PY, Lin HY, Chiappori AA, Gabrilovich DI, Haura EB, Antonia SJ, Gray JE.

Oncotarget. 2017 Jul 7;8(51):88376-88385. doi: 10.18632/oncotarget.19088. eCollection 2017 Oct 24.

31.

Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.

Soria JC, Ohe Y, Vansteenkiste J, Reungwetwattana T, Chewaskulyong B, Lee KH, Dechaphunkul A, Imamura F, Nogami N, Kurata T, Okamoto I, Zhou C, Cho BC, Cheng Y, Cho EK, Voon PJ, Planchard D, Su WC, Gray JE, Lee SM, Hodge R, Marotti M, Rukazenkov Y, Ramalingam SS; FLAURA Investigators.

N Engl J Med. 2018 Jan 11;378(2):113-125. doi: 10.1056/NEJMoa1713137. Epub 2017 Nov 18.

32.

The Cys-Arg/N-End Rule Pathway Is a General Sensor of Abiotic Stress in Flowering Plants.

Vicente J, Mendiondo GM, Movahedi M, Peirats-Llobet M, Juan YT, Shen YY, Dambire C, Smart K, Rodriguez PL, Charng YY, Gray JE, Holdsworth MJ.

Curr Biol. 2017 Oct 23;27(20):3183-3190.e4. doi: 10.1016/j.cub.2017.09.006. Epub 2017 Oct 12.

33.

Management of Progressive Pulmonary Nodules Found during and outside of CT Lung Cancer Screening Studies.

Meyer M, Vliegenthart R, Henzler T, Buergy D, Giordano FA, Kostrzewa M, Rathmann N, Brustugun OT, Crino L, Dingemans AC, Dusmet M, Fennell D, Grunenwald D, Huber RM, Moniuszko M, Mornex F, Papotti M, Pilz L, Senan S, Syrigos K, Pérol M, Gray JE, Schabel C, van Meerbeeck JP, van Zandwijk N, Zhou CC, Manegold C, Voigt W, Roessner ED.

J Thorac Oncol. 2017 Dec;12(12):1755-1765. doi: 10.1016/j.jtho.2017.09.1956. Epub 2017 Sep 27. Review.

34.

Stomatal Opening Involves Polar, Not Radial, Stiffening Of Guard Cells.

Carter R, Woolfenden H, Baillie A, Amsbury S, Carroll S, Healicon E, Sovatzoglou S, Braybrook S, Gray JE, Hobbs J, Morris RJ, Fleming AJ.

Curr Biol. 2017 Oct 9;27(19):2974-2983.e2. doi: 10.1016/j.cub.2017.08.006. Epub 2017 Sep 21.

35.

Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors.

Creelan BC, Gabrilovich DI, Gray JE, Williams CC, Tanvetyanon T, Haura EB, Weber JS, Gibney GT, Markowitz J, Proksch JW, Reisman SA, McKee MD, Chin MP, Meyer CJ, Antonia SJ.

Onco Targets Ther. 2017 Aug 29;10:4239-4250. doi: 10.2147/OTT.S136992. eCollection 2017.

36.

Factors Associated With Pediatric Ventilator-Associated Conditions in Six U.S. Hospitals: A Nested Case-Control Study.

Cocoros NM, Priebe G, Gray JE, Toltzis P, Larsen GY, Logan LK, Coffin S, Sammons JS, Deakins K, Horan K, Lakoma M, Young J, Burton M, Klompas M, Lee GM.

Pediatr Crit Care Med. 2017 Nov;18(11):e536-e545. doi: 10.1097/PCC.0000000000001328.

PMID:
28914722
37.

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.

Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Yokoi T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim YC, Karapetis CS, Hiret S, Ostoros G, Kubota K, Gray JE, Paz-Ares L, de Castro Carpeño J, Wadsworth C, Melillo G, Jiang H, Huang Y, Dennis PA, Özgüroğlu M; PACIFIC Investigators.

N Engl J Med. 2017 Nov 16;377(20):1919-1929. doi: 10.1056/NEJMoa1709937. Epub 2017 Sep 8.

38.

Cell-free circulating tumor DNA supplementing tissue biopsies for identification of targetable mutations: Implications for precision medicine and considerations for reconciling results.

Hicks JK, Saller J, Wang E, Boyle T, Gray JE.

Lung Cancer. 2017 Sep;111:135-138. doi: 10.1016/j.lungcan.2017.06.015. Epub 2017 Jun 23.

PMID:
28838384
39.

Stomatal development: focusing on the grasses.

Hepworth C, Caine RS, Harrison EL, Sloan J, Gray JE.

Curr Opin Plant Biol. 2018 Feb;41:1-7. doi: 10.1016/j.pbi.2017.07.009. Epub 2017 Aug 18. Review.

40.

Anti PD-L1 combined with other agents in non-small cell lung cancer: combinations with non-immuno-oncology agents.

Puri S, Chatwal M, Gray JE.

Expert Rev Respir Med. 2017 Oct;11(10):791-805. doi: 10.1080/17476348.2017.1361323. Epub 2017 Aug 8. Review.

PMID:
28786318
41.

Therapy of Small Cell Lung Cancer (SCLC) with a Topoisomerase-I-inhibiting Antibody-Drug Conjugate (ADC) Targeting Trop-2, Sacituzumab Govitecan.

Gray JE, Heist RS, Starodub AN, Camidge DR, Kio EA, Masters GA, Purcell WT, Guarino MJ, Misleh J, Schneider CJ, Schneider BJ, Ocean A, Johnson T, Gandhi L, Kalinsky K, Scheff R, Messersmith WA, Govindan SV, Maliakal PP, Mudenda B, Wegener WA, Sharkey RM, Goldenberg DM.

Clin Cancer Res. 2017 Oct 1;23(19):5711-5719. doi: 10.1158/1078-0432.CCR-17-0933. Epub 2017 Jul 5.

42.

Pathology Issues in Thoracic Oncology: Histologic Characterization and Tissue/Plasma Genotyping May Resolve Diagnostic Dilemmas.

Dagogo-Jack I, Saltos A, Shaw AT, Gray JE.

Am Soc Clin Oncol Educ Book. 2017;37:619-629. doi: 10.14694/EDBK_175197. Review.

43.

Dual Targeting of WEE1 and PLK1 by AZD1775 Elicits Single Agent Cellular Anticancer Activity.

Wright G, Golubeva V, Remsing Rix LL, Berndt N, Luo Y, Ward GA, Gray JE, Schonbrunn E, Lawrence HR, Monteiro ANA, Rix U.

ACS Chem Biol. 2017 Jul 21;12(7):1883-1892. doi: 10.1021/acschembio.7b00147. Epub 2017 Jun 7.

44.

Outcomes targeting the PD-1/PD-L1 axis in conjunction with stereotactic radiation for patients with non-small cell lung cancer brain metastases.

Ahmed KA, Kim S, Arrington J, Naghavi AO, Dilling TJ, Creelan BC, Antonia SJ, Caudell JJ, Harrison LB, Sahebjam S, Gray JE, Etame AB, Johnstone PA, Yu M, Perez BA.

J Neurooncol. 2017 Jun;133(2):331-338. doi: 10.1007/s11060-017-2437-5. Epub 2017 May 2.

PMID:
28466250
45.

Reducing Stomatal Density in Barley Improves Drought Tolerance without Impacting on Yield.

Hughes J, Hepworth C, Dutton C, Dunn JA, Hunt L, Stephens J, Waugh R, Cameron DD, Gray JE.

Plant Physiol. 2017 Jun;174(2):776-787. doi: 10.1104/pp.16.01844. Epub 2017 May 1.

46.

Origins and Evolution of Stomatal Development.

Chater CCC, Caine RS, Fleming AJ, Gray JE.

Plant Physiol. 2017 Jun;174(2):624-638. doi: 10.1104/pp.17.00183. Epub 2017 Mar 29. Review.

47.

CRISPR-Cas9 and CRISPR-Cpf1 mediated targeting of a stomatal developmental gene EPFL9 in rice.

Yin X, Biswal AK, Dionora J, Perdigon KM, Balahadia CP, Mazumdar S, Chater C, Lin HC, Coe RA, Kretzschmar T, Gray JE, Quick PW, Bandyopadhyay A.

Plant Cell Rep. 2017 May;36(5):745-757. doi: 10.1007/s00299-017-2118-z. Epub 2017 Mar 27.

48.

Any action? Reflections on the Australian Midwifery Action Project.

Gray JE, Smith RM.

Women Birth. 2017 Jun;30(3):177-183. doi: 10.1016/j.wombi.2017.02.008. Epub 2017 Mar 23.

PMID:
28344025
49.

High-risk community and primary care providers knowledge about and barriers to low-dose computed topography lung cancer screening.

Simmons VN, Gray JE, Schabath MB, Wilson LE, Quinn GP.

Lung Cancer. 2017 Apr;106:42-49. doi: 10.1016/j.lungcan.2017.01.012. Epub 2017 Jan 31.

PMID:
28285693
50.

Formation of the Stomatal Outer Cuticular Ledge Requires a Guard Cell Wall Proline-Rich Protein.

Hunt L, Amsbury S, Baillie A, Movahedi M, Mitchell A, Afsharinafar M, Swarup K, Denyer T, Hobbs JK, Swarup R, Fleming AJ, Gray JE.

Plant Physiol. 2017 Jun;174(2):689-699. doi: 10.1104/pp.16.01715. Epub 2017 Feb 2.

Supplemental Content

Support Center